Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice

被引:28
作者
Russell, P
Eley, SM
Bell, DL
Manchee, RJ
Titball, RW
机构
[1] CBDE Porton Down, Salisbury
关键词
D O I
10.1093/jac/37.4.769
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The efficacy of doxycycline and ciprofloxacin against an experimental plague infection was assessed by comparing the median lethal dose (MLD) of Yersinia pestis in antibiotic-treated and untreated mice. The MLD of Y, pestis GB strain in untreated mice by the intra-peritoneal route was 23 cfu. If ciprofloxacin dosage (20 or 40 mg/kg twice daily) was initiated 48 h before infection, it afforded complete protection against an intra-peritoneal challenge of 5.24 x 10(7) cfu. Ciprofloxacin therapy initiated 24 h post-challenge was less protective, the MLD was raised to 2.0 x 10(5) and 2.2 x 10(5) cfu for 40 and 20 mg/kg respectively. Doxycycline dosage (40 mg/kg twice daily) initiated 48 h prior to infection raised the MLD to 1.6 x 10(4) cfu, but other prophylactic and therapeutic regimes were ineffective against challenges greater than 6.76 x 10(2) cfu. Ciprofloxacin may therefore be a useful antibiotic to consider for the treatment of plague.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 11 条
[1]   ASSESSMENT OF A FLUOROQUINOLONE, 3 BETA-LACTAMS, 2 AMINOGLYCOSIDES, AND A CYCLINE IN TREATMENT OF MURINE YERSINIA-PESTIS INFECTION [J].
BONACORSI, SP ;
SCAVIZZI, MR ;
GUIYOULE, A ;
AMOUROUX, JH ;
CARNIEL, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :481-486
[2]   YERSINIA-PESTIS INFECTION IN VIETNAM .2. QUANTITATIVE BLOOD CULTURES AND DETECTION OF ENDOTOXIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH MENINGITIS [J].
BUTLER, T ;
LEVIN, J ;
LINH, NN ;
CHAU, DM ;
ADICKMAN, M ;
ARNOLD, K .
JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (05) :493-499
[3]  
BUTLER T, 1979, PEDIATR CLIN N AM, V26, P355
[4]  
Butler T., 1983, Plague and Other Yersinia Infections
[5]  
BUTLER T, 1995, PRINCIPLES PRACTICE, V2
[6]   THE POSSIBLE ROLE OF QUINOLONES IN YERSINIOSIS [J].
HOOGKAMPKORSTANJE, JAA .
DRUGS, 1987, 34 :134-138
[7]  
Lambert H. P, 1992, ANTIBIOTIC CHEMOTHER
[8]  
MCCBRUMB FR, 1953, AM J MED, V41, P284
[9]  
REED L. J., 1938, AMER JOUR HYG, V27, P493
[10]   A COMPARISON OF PLAGUE VACCINE, USP AND EV76 VACCINE-INDUCED PROTECTION AGAINST YERSINIA-PESTIS IN A MURINE MODEL [J].
RUSSELL, P ;
ELEY, SM ;
HIBBS, SE ;
MANCHEE, RJ ;
STAGG, AJ ;
TITBALL, RW .
VACCINE, 1995, 13 (16) :1551-1556